Home/Filings/4/0001127602-23-030187
4//SEC Filing

Stonehouse Jon P 4

Accession 0001127602-23-030187

CIK 0000882796other

Filed

Dec 19, 7:00 PM ET

Accepted

Dec 20, 4:40 PM ET

Size

6.2 KB

Accession

0001127602-23-030187

Insider Transaction Report

Form 4
Period: 2023-12-19
Stonehouse Jon P
DirectorPresident & CEO
Transactions
  • Tax Payment

    Common Stock

    2023-12-19$6.05/sh14,089$85,2381,114,770 total
Holdings
  • Common Stock

    (indirect: By Trust)
    10,000
  • Common Stock

    (indirect: By Trust)
    10,000
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to satisfy required tax withholding obligations in connection with the vesting of previously granted Restricted Stock Units. This transaction does not represent a sale by the reporting person.

Issuer

BIOCRYST PHARMACEUTICALS INC

CIK 0000882796

Entity typeother

Related Parties

1
  • filerCIK 0001385496

Filing Metadata

Form type
4
Filed
Dec 19, 7:00 PM ET
Accepted
Dec 20, 4:40 PM ET
Size
6.2 KB